" class="no-js "lang="en-US"> Mehdi Adineh - Medtech Alert
Tuesday, August 19, 2025
Mehdi Adineh

Mehdi Adineh

About Mehdi Adineh

Over 15 years’ experience in Phase I-IV clinical trials protocol development and management services for NIH/NCI, pharmaceutical, biotechnology and medical device organizations.

Imaging physicist with extensive experience in Medical Imaging industry including diagnostic imaging as well as clinical trials:

– Advising pharmaceutical/biotech industry in effective integration of imaging endpoints in their clinical protocols to establish efficacy and safety of their compounds
– Development of Independent Review Charter involving multidisciplinary imaging (MRI, CT, PET, US)
– Site training/qualification
– Image-data Quality Assurance
– Image processing
– Execution of blind reads for submission to FDA and other global regulatory agencies.
– Solid understanding of clinical trials imagines systems (data transmission/tracking,

CTMS, EDC and analytical workstations), SOP-driven processes, and deployment of CFR-Part 11 compliant IT solutions for imaging trials.

Related Story

Top Pharmaceutical Companies and CROs Rely on Vivalink for Real-World Patient Data in Decentralized Clinical Trials

September 29 2021

Due to limitations necessitated by COVID-19, clinical trials have undergone a transformation. In tandem with […]